Journal article
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
- Abstract:
-
Background
Growing evidence suggests that blood eosinophil count is associated with patient responsiveness to inhaled corticosteroids (ICS). We performed post hoc predictive modeling on data from the FORWARD study and two replicate studies by Dransfield, to evaluate the relationships between baseline eosinophil count and the effect of ICS on exacerbations and lung function in patients with COPD.
Methods
The studies assessed ICS/long-acting β2 agonist (LABA) combin...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 2.6MB)
-
- Publisher copy:
- 10.2147/COPD.S179425
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
National Institute for Health Research
More from this funder
Chiesi Farmaceutici SpA
More from this funder
GlaxoSmithKline
More from this funder
Bibliographic Details
- Publisher:
- Dove Press Publisher's website
- Journal:
- International Journal of Chronic Obstructive Pulmonary Disease Journal website
- Volume:
- 13
- Pages:
- 3669-3676
- Publication date:
- 2018-11-06
- Acceptance date:
- 2018-10-12
- DOI:
- ISSN:
-
1178-2005 and 1176-9106
- Pmid:
-
30464449
- Source identifiers:
-
949005
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:949005
- UUID:
-
uuid:02e4a6b8-3142-4626-af8e-03201f47a67e
- Local pid:
- pubs:949005
- Deposit date:
- 2018-12-17
Terms of use
- Copyright holder:
- Siddiqui et al
- Copyright date:
- 2018
- Notes:
- © 2018 Siddiqui et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
If you are the owner of this record, you can report an update to it here: Report update to this record